This reference collects the latest scientific evidence illustrating the increasing importance of pharmacoinvasive therapy in the treatment of ST elevation acute myocardial infarction-tracking the origins, evolution, and limitations of current treatment methods and highlighting new clinical trial data showcasing the potential of the combined treatment approach and controversial issues surrounding this emerging therapeutic modality.
Author(s): Harold L. Dauerman, Burton E. Sobel
Series: Fundamental and Clinical Cardiology
Edition: 1
Publisher: Informa Healthcare
Year: 2005
Language: English
Pages: 263
Series Introduction......Page 8
Preface......Page 10
Contributors......Page 14
Contents......Page 16
1. The Rationale Underlying Pharmacoinvasive Therapy......Page 20
2. Development, Impact, and Limitations of Coronary Thrombolysis: Milestones in Pharmacological Reperfusion Therapy......Page 50
3. The United Arab Emirates Experience: Treatment of Patients with Acute ST Elevation Myocardial Infarction with Thrombolytic Drugs......Page 84
4. Development, Impact, and Limitations of Primary Percutaneous Coronary Intervention for the Treatment of ST Elevation Myocardial Infarction......Page 96
5. Diminished Enthusiasm Reflecting Complications in Early Trials of Thrombolysis Followed by Coronary Intervention......Page 136
6. The Rebirth of Interest in Pharmacoinvasive Therapy in the Stent Era......Page 148
7. Pharmacological Developments Likely to Enhance the Benefits of Pharmacoinvasive Therapy......Page 166
8. Design and Overview of Contemporary Studies of Pharmacoinvasive Therapy......Page 200
9. Considerations in Reperfusion Therapy of Elderly Patients with ST Elevation Acute Myocardial Infarction......Page 226
10. Controversy and Convergence......Page 248
Index......Page 256
